Technology Review Djibouti : Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Review Djibouti .

Press releases published on July 7, 2026

Jul. 7, 2026

Arnatar Therapeutics Receives China NMPA Clearance to Initiate First-in-Human Study of ART5, a First-in-Class Up-Regulating ASO Designed to Restore Polycystin-1 for the Treatment of ADPKD

Indeterminate GlobeNewswire

Jul. 7, 2026

Byrna Technologies Selects Acceleration Partners to Expand Creator Network and Relaunch Affiliate Marketing Program

Indeterminate GlobeNewswire

Jul. 7, 2026

zSpace Powers Immersive Career Exploration at Poland's New Laboratorium 4.0

Indeterminate GlobeNewswire

Jul. 7, 2026

Certara Accelerates Drug Discovery and Development with NVIDIA BioNeMo Agent Toolkit

Indeterminate GlobeNewswire

Jul. 7, 2026

Kahuna Labs Introduces AI-Powered Escalation Prevention to Help Enterprises Stop Escalations Before They Happen

Indeterminate GlobeNewswire

Jul. 7, 2026

Enlivex Announces 1-for-15 Reverse Stock Split Effective July 9, 2026

Indeterminate GlobeNewswire

Jul. 7, 2026

BIO-key Regains Compliance with Nasdaq Listing Rules; Nasdaq Trading Resumes on Wednesday, July 8th

Indeterminate GlobeNewswire

Jul. 7, 2026

Acumen Pharmaceuticals to Present Data on Enhanced Brain Delivery™ (EBD™) Technology and Early Alzheimer’s Disease Insights at the Alzheimer’s Association International Conference (AAIC®) 2026

Indeterminate GlobeNewswire

Jul. 7, 2026

Cornerstone First Mortgage Switches to nCino's Mortgage Point of Sale to Support Its Next Phase of Growth

Indeterminate GlobeNewswire

Jul. 7, 2026

ZenaTech’s ZenaDrone Advances Defense Drone Portfolio with Initial IQ Sphere Prototype for Autonomous GPS-Denied Inspections, Surveillance and Reconnaissance Missions

Indeterminate GlobeNewswire

Jul. 7, 2026

AI Takes Center Stage at Blockchain Futurist Conference 2026

Indeterminate GlobeNewswire

Jul. 7, 2026

Alterity Therapeutics Receives FDA End-of-Phase 2 Meeting Minutes Confirming Registrational Pathway for ATH434 in Multiple System Atrophy

Indeterminate GlobeNewswire

Jul. 7, 2026

Aquestive Therapeutics to Participate in Leerink Partners Therapeutics Forum: I&I and Metabolism

Indeterminate GlobeNewswire

Jul. 7, 2026

Avalo Therapeutics to Participate in the Leerink Partners Therapeutics Forum

Indeterminate GlobeNewswire

Jul. 7, 2026

Nuvini Retires R$61 Million Debenture Facility in Full

Indeterminate GlobeNewswire

Jul. 7, 2026

Axsome Therapeutics Initiates FOCUS-2 Phase 3 Trial of Solriamfetol in Children with Attention Deficit Hyperactivity Disorder (ADHD)

Indeterminate GlobeNewswire

Jul. 7, 2026

Aeluma CEO to Chair Optica Advanced Photonics Congress Industry Program on AI and Quantum

Indeterminate GlobeNewswire

Jul. 7, 2026

Annovis Reaches Full Enrollment in Pivotal Phase 3 Trial of Buntanetap for Early Alzheimer’s Disease

Indeterminate GlobeNewswire

Jul. 7, 2026

WRAP Launches WrapShield: An Autonomous Defense & Public Safety Platform, Beginning with Advanced Thermal Polarimetric Sensing for Counter-UAS and Expanding Across AI-Enabled Security Responses

Indeterminate GlobeNewswire

Jul. 7, 2026

OKYO Pharma to Participate in a Fireside Chat at Piper Sandler 2026 Virtual Ophthalmology Symposium

Indeterminate GlobeNewswire